Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112071 · ClinicalTrials.gov registry record · NA
Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT02112071 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 122 participants.
The verdict
NCT02112071, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).
Interventions
- BEHAVIORAL Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112071
The ClinicalTrials.gov registry entry for NCT02112071 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT02112071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02112071 about?
NCT02112071 is a clinical study titled "Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.". The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).
What is the current status of trial NCT02112071?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2009-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02112071?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112071?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.